Imagion Biosystems has released Appendix 3Z Final Director’s Interest Notice. Read the Final Director’s Interest Notice.
Positive independent review sets priority path to market for MagSense® Technology
Highlights Blinded review by panel of expert breast radiologists corroborates potential for MagSense® nanoparticle technology to detect tumour cells in lymph nodes by Magnetic Resonance